ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 175 filers reported holding ANI PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $140,000 | – | 2,096 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mesirow Financial Investment Management, Inc. | 9,433 | $266,000 | 1.14% |
| Global Alpha Capital Management Ltd. | 258,946 | $7,305,000 | 1.12% |
| Birch Grove Capital LP | 50,791 | $1,433,000 | 0.78% |
| 1492 Capital Management LLC | 25,003 | $705,000 | 0.53% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 321,975 | $9,083,000 | 0.41% |
| THB ASSET MANAGEMENT | 48,385 | $1,364,000 | 0.38% |
| Regent Investment Management LLC | 36,979 | $1,043,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 41,212 | $1,163,000 | 0.31% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $1,001,000 | 0.26% |
| Ranger Investment Management | 124,763 | $3,520,000 | 0.22% |